Clinical Trial Update: Edaravone on the Ischemia-Reperfusion(I/R) Injury in Kidney Transplantation Patients [NA]

View source ↗

Summary

A clinical trial is studying edaravone for ischemia-reperfusion injury in kidney transplantation patients. The current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Edaravone (Edaravone)

Snippet

Sponsor: Xijing Hospital | Conditions: Kidney Transplantation | NA | Status: UNKNOWN